Business Context and Reporting Period
This Form 8-K Current Report was filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on May 28, 2015, with the report date signed on June 3, 2015. The filing primarily addresses corporate governance changes and regulatory disclosures regarding investor presentations.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses on non-financial corporate events.
Material Changes
- Board Appointment: On May 28, 2015, Mr. Matthew Pfeffer was appointed to the Board of Directors and named Chair of the Audit Committee.
- Director Qualifications: The Board determined Mr. Pfeffer qualifies as an independent director under NASDAQ Listing Rules and as a financial expert under the Sarbanes-Oxley Act of 2002.
- Regulatory Disclosure: The company disclosed presentation materials intended for use at investor conferences in New York City and Boston on June 3 and June 4, 2015.
Guidance, Outlook, and Risks
The filing incorporates by reference a press release and investor presentation materials (Exhibit 99.2). The company explicitly disclaims any obligation to update these materials to reflect events occurring after the date of this report. No specific forward-looking guidance, risks, or contingencies are detailed within the text of this 8-K filing itself.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for details on the board appointment.
- Review the investor presentation materials (Exhibit 99.2) for the most recent strategic outlook and financial projections, noting the disclaimer that they may not be updated.
- Confirm Mr. Matthew Pfeffer's background and independence status as described in the filing.
- Note that this filing contains no audited financial statements or quarterly results.